A Eggermont
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
Papers in
-
- Melanoma and MAPK Pathways 3
- Angiogenesis and VEGF in Cancer 1
- Oncology 5
- Cutaneous Melanoma Detection and Management 3
- Cancer Treatment and Pharmacology 1
- Co-authors
- Ulrich Keilholz (2 shared papers)Hans Loibner (1 shared paper)Kristen Hege (1 shared paper)Brent A. Blumenstein (1 shared paper)Geoffrey Nichol (1 shared paper)Giorgio Parmiani (1 shared paper)Natalie Sacks (1 shared paper)Mario Sznol (1 shared paper)
- Journals
- Journal of Chromatography A (2 papers)Journal of Clinical Oncology (1 paper)Melanoma Research (1 paper)International Journal of Cancer (1 paper)Journal of Immunotherapy (1 paper)
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
A Eggermont
8 papers receiving 365 citations
Peers
Comparison fields: 5 of 65
- Immunology 178
- Oncology 216
- Cancer Research 46
- Molecular Biology 173
- Immunology and Allergy 14
Countries citing papers authored by A Eggermont
This map shows the geographic impact of A Eggermont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Eggermont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Eggermont more than expected).
Fields of papers citing papers by A Eggermont
This network shows the impact of papers produced by A Eggermont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Eggermont. The network helps show where A Eggermont may publish in the future.
Co-authors
The 25 scholars most cited alongside A Eggermont, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 197 | |
| 2 | 2007 | 54 | |
| 3 | 2000 | 46 | |
| 4 | Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma. | 1994 | 37 |
| 5 | 2002 | 22 | |
| 6 | 2002 | 16 | |
| 7 | [Efficacy of the tumor necrosis factor-alpha (rTNF-alpha) associated with interferon-gamma and chemotherapy in extracorporeal circulation in the limb in inoperable malignant melanoma, soft tissue sarcoma and epidermoid carcinoma. A 4-year experience]. | 1995 | 3 |
| 8 | 1997 | 2 | |
| 9 | Serum S100B protein evaluation in an EORTC randomized melanoma trial: A first report | 2006 | 0 |
About A Eggermont
A Eggermont is a scholar working on Molecular Biology, Oncology, Genetics, Immunology and Allergy and Organic Chemistry, having authored 9 papers that have together received 377 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (3 papers), Melanoma and MAPK Pathways (3 papers), Cell Adhesion Molecules Research (2 papers), Virus-based gene therapy research (2 papers), Cancer Treatment and Pharmacology (1 paper), Analytical Chemistry and Chromatography (1 paper), Click Chemistry and Applications (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Immunology (178 citations), Oncology (216 citations), Cancer Research (46 citations), Molecular Biology (173 citations) and Immunology and Allergy (14 citations). A Eggermont has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Ulrich Keilholz, Hans Loibner, Kristen Hege, Brent A. Blumenstein, Geoffrey Nichol, Giorgio Parmiani, Natalie Sacks, Mario Sznol, Axel Hoos and Walter J. Urba. Their work appears in journals such as Journal of Chromatography A, Journal of Clinical Oncology, Melanoma Research, International Journal of Cancer and Journal of Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.